Drug therapy lenacapavir may effectively control HIV in Uganda

by

A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.

Leave A Comment

Your email address will not be published. Required fields are marked *